患者对全基因组测序在其医疗保健中的感知效用：MedSeq项目的研究结果。
Patients' perceived utility of whole-genome sequencing for their healthcare: findings from the MedSeq project.
作者信息
Lupo Philip J, Robinson Jill O, Diamond Pamela M, Jamal Leila, Danysh Heather E, Blumenthal-Barby Jennifer, Lehmann Lisa Soleymani, Vassy Jason L, Christensen Kurt D, Green Robert C, McGuire Amy L
机构信息
Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, TX 77030, USA.
Center for Medical Ethics & Health Policy, Baylor College of Medicine, Houston, TX 77030, USA.
出版信息
Per Med. 2016 Jan 1;13(1):13-20. doi: 10.2217/pme.15.45. Epub 2016 Jan 8.
Abstract
AIM
To evaluate patients' expectations regarding the perceived utility of whole-genome sequencing (WGS).
MATERIALS & METHODS: We used latent class analysis to characterize individuals enrolled in the MedSeq Project based on their perceived utility of WGS. Multinomial logistic regression was used to evaluate associations between participant characteristics and latent classes.
RESULTS
Findings characterized participants into one of three perceived utility groups: enthusiasts, who had a high probability of agreement with all utility items (23%); health conscious, who perceived utility in medically related areas (60%) or skeptics, who had a low probability of agreement with utility items (17%). Trust significantly predicted latent class.
CONCLUSION
Understanding differences in perceived utility of WGS may inform strategies for uptake of this technology.
摘要
目的
评估患者对全基因组测序（WGS）感知效用的期望。
材料与方法
我们使用潜在类别分析，根据全基因组测序的感知效用对参与MedSeq项目的个体进行特征描述。多项逻辑回归用于评估参与者特征与潜在类别之间的关联。
结果
研究结果将参与者分为三个感知效用组之一：热心者，他们对所有效用项目高度认同的可能性很高（23%）；健康意识者，他们在医学相关领域感知到效用（60%）；或怀疑者，他们对效用项目认同的可能性很低（17%）。信任显著预测潜在类别。
结论
了解全基因组测序感知效用的差异可能为该技术的应用策略提供信息。
相似文献
1
Patients' perceived utility of whole-genome sequencing for their healthcare: findings from the MedSeq project.患者对全基因组测序在其医疗保健中的感知效用：MedSeq项目的研究结果。
Per Med. 2016 Jan 1;13(1):13-20. doi: 10.2217/pme.15.45. Epub 2016 Jan 8.
2
Patient understanding of, satisfaction with, and perceived utility of whole-genome sequencing: findings from the MedSeq Project.患者对全基因组测序的理解、满意度和感知效用：MedSeq 项目的研究结果。
Genet Med. 2018 Sep;20(9):1069-1076. doi: 10.1038/gim.2017.223. Epub 2018 Jan 4.
3
The price of whole-genome sequencing may be decreasing, but who will be sequenced?全基因组测序的价格可能在下降，但谁会接受测序呢？
Per Med. 2017 May;14(3):203-211. doi: 10.2217/pme-2016-0075. Epub 2017 May 23.
4
'Someday it will be the norm': physician perspectives on the utility of genome sequencing for patient care in the MedSeq Project.“终有一天这将成为常态”：医生对MedSeq项目中基因组测序在患者护理中的效用的看法。
Per Med. 2015;12(1):23-32. doi: 10.2217/pme.14.68.
5
Whole genome sequencing as the ultimate tool to diagnose tuberculosis.全基因组测序作为诊断结核病的终极工具。
Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S60-S61. doi: 10.1016/j.ijmyco.2016.10.036. Epub 2016 Nov 24.
6
Reporting results from whole-genome and whole-exome sequencing in clinical practice: a proposal for Canada?在临床实践中报告全基因组和全外显子组测序结果：加拿大的一项提议？
J Med Genet. 2014 Jan;51(1):68-70. doi: 10.1136/jmedgenet-2013-101934. Epub 2013 Sep 27.
7
Young adults' attitudes toward pediatric whole-genome sequencing.年轻人对儿科全基因组测序的态度。
Per Med. 2016 Nov;13(6):541-552. doi: 10.2217/pme-2016-0066. Epub 2016 Sep 13.
8
Reducing INDEL calling errors in whole genome and exome sequencing data.降低全基因组和外显子组测序数据中 INDEL 调用错误。
Genome Med. 2014 Oct 28;6(10):89. doi: 10.1186/s13073-014-0089-z. eCollection 2014.
9
Whole-genome sequencing improves discrimination of relapse from reinfection and identifies transmission events among patients with recurrent Clostridium difficile infections.全基因组测序提高了对复发性艰难梭菌感染患者复发与再感染的区分能力，并鉴定了传播事件。
J Hosp Infect. 2015 Jun;90(2):108-16. doi: 10.1016/j.jhin.2015.01.021. Epub 2015 Feb 26.
10
A systematic approach to the reporting of medically relevant findings from whole genome sequencing.一种用于报告全基因组测序医学相关发现的系统方法。
BMC Med Genet. 2014 Dec 14;15:134. doi: 10.1186/s12881-014-0134-1.
引用本文的文献
1
Attitudes, knowledge, and risk perceptions of patients who received elective genomic testing as a clinical service.接受临床服务的选择性基因组检测患者的态度、知识和风险认知。
Genet Med. 2024 Oct;26(10):101200. doi: 10.1016/j.gim.2024.101200. Epub 2024 Jun 26.
2
Evaluating parental personal utility of pediatric genetic and genomic testing in a diverse, multilingual population.评估儿科基因和基因组检测在多元化、多语言人群中对父母个人的效用。
HGG Adv. 2024 Jul 18;5(3):100321. doi: 10.1016/j.xhgg.2024.100321. Epub 2024 Jun 24.
3
Research Participants' Perspectives on Precision Diagnostics for Alzheimer's Disease.阿尔茨海默病精准诊断研究参与者的观点。
J Alzheimers Dis. 2024;97(3):1261-1274. doi: 10.3233/JAD-230609.
4
Demographic Characteristics Associated With Perceptions of Personal Utility in Genetic and Genomic Testing: A Systematic Review.与遗传和基因组检测中个人效用感知相关的人口统计学特征：系统评价。
JAMA Netw Open. 2023 May 1;6(5):e2310367. doi: 10.1001/jamanetworkopen.2023.10367.
5
Patient and Clinician Perceptions of Precision Cardiology Care: Findings From the HeartCare Study.患者和临床医生对精准心脏病学护理的看法：来自 HeartCare 研究的结果。
Circ Genom Precis Med. 2022 Dec;15(6):e003605. doi: 10.1161/CIRCGEN.121.003605. Epub 2022 Oct 25.
6
Perceived utility and disutility of genomic sequencing for pediatric patients: Perspectives from parents with diverse sociodemographic characteristics.家长对儿科患者进行基因组测序的感知效用和不效用：来自具有不同社会人口统计学特征的家长的观点。
Am J Med Genet A. 2022 Apr;188(4):1088-1101. doi: 10.1002/ajmg.a.62619. Epub 2022 Jan 3.
7
Conceptualization of utility in translational clinical genomics research.转化临床基因组学研究中效用的概念化。
Am J Hum Genet. 2021 Nov 4;108(11):2027-2036. doi: 10.1016/j.ajhg.2021.08.013. Epub 2021 Oct 22.
8
Perceived Utility of Genomic Sequencing: Qualitative Analysis and Synthesis of a Conceptual Model to Inform Patient-Centered Instrument Development.基因组测序的感知效用：概念模型的定性分析和综合，为以患者为中心的仪器开发提供信息。
Patient. 2022 May;15(3):317-328. doi: 10.1007/s40271-021-00558-4. Epub 2021 Oct 18.
9
A study of elective genome sequencing and pharmacogenetic testing in an unselected population.一项在未选择人群中进行的选择性基因组测序和药物遗传学检测研究。
Mol Genet Genomic Med. 2021 Sep;9(9):e1766. doi: 10.1002/mgg3.1766. Epub 2021 Jul 27.
10
Utility of Genetic Testing from the Perspective of Parents/Caregivers: A Scoping Review.从父母/照顾者角度看基因检测的效用：一项范围综述
Children (Basel). 2021 Mar 27;8(4):259. doi: 10.3390/children8040259.
本文引用的文献
1
'Someday it will be the norm': physician perspectives on the utility of genome sequencing for patient care in the MedSeq Project.“终有一天这将成为常态”：医生对MedSeq项目中基因组测序在患者护理中的效用的看法。
Per Med. 2015;12(1):23-32. doi: 10.2217/pme.14.68.
2
A framework for analyzing the ethics of disclosing genetic research findings.分析基因研究结果披露伦理问题的框架。
J Law Med Ethics. 2014 Summer;42(2):190-207. doi: 10.1111/jlme.12135.
3
Personal utility in genomic testing: is there such a thing?基因检测中的个人效用：有这样的东西吗？
J Med Ethics. 2015 Apr;41(4):322-6. doi: 10.1136/medethics-2013-101887. Epub 2014 May 28.
4
The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine.MedSeq 项目：将全基因组测序整合到临床医学中的一项随机试验。
Trials. 2014 Mar 20;15:85. doi: 10.1186/1745-6215-15-85.
5
Adult genetic risk screening.成人遗传风险筛查。
Annu Rev Med. 2014;65:1-17. doi: 10.1146/annurev-med-111212-144716. Epub 2013 Nov 4.
6
Implementing genomic medicine in the clinic: the future is here.将基因组医学付诸临床实践：未来已来。
Genet Med. 2013 Apr;15(4):258-67. doi: 10.1038/gim.2012.157. Epub 2013 Jan 10.
7
The privacy-reciprocity connection in biobanking: comparing German with UK strategies.生物样本库中的隐私与互惠关系：德国与英国策略之比较
Public Health Genomics. 2012;15(5):272-84. doi: 10.1159/000336671. Epub 2012 Jun 20.
8
Patients' understanding of and responses to multiplex genetic susceptibility test results.患者对多重遗传易感性测试结果的理解和反应。
Genet Med. 2012 Jul;14(7):681-7. doi: 10.1038/gim.2012.22.
9
Biobank participation and returning research results: perspectives from a deliberative engagement in South Side Chicago.生物银行参与和研究结果返还：来自芝加哥南侧参与式审议的观点。
Am J Med Genet A. 2012 May;158A(5):1029-37. doi: 10.1002/ajmg.a.34414. Epub 2012 Mar 21.
10
Willingness to pay for genetic testing for Alzheimer's disease: a measure of personal utility.为阿尔茨海默病基因检测支付费用的意愿：一种个人效用的衡量方式。
Genet Test Mol Biomarkers. 2011 Dec;15(12):871-5. doi: 10.1089/gtmb.2011.0028. Epub 2011 Jul 12.
Zotero 插件